WSO-B vs. NVO
Compare and contrast key facts about Watsco Inc (WSO-B) and Novo Nordisk A/S (NVO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: WSO-B or NVO.
Correlation
The correlation between WSO-B and NVO is 0.20, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
WSO-B vs. NVO - Performance Comparison
Loading data...
Key characteristics
WSO-B:
0.29
NVO:
-1.17
WSO-B:
0.60
NVO:
-1.66
WSO-B:
1.22
NVO:
0.79
WSO-B:
0.55
NVO:
-0.81
WSO-B:
1.58
NVO:
-1.50
WSO-B:
5.33%
NVO:
32.04%
WSO-B:
29.41%
NVO:
42.60%
WSO-B:
-61.63%
NVO:
-71.29%
WSO-B:
-10.83%
NVO:
-54.60%
Fundamentals
WSO-B:
$18.94B
NVO:
$295.20B
WSO-B:
$12.94
NVO:
$3.53
WSO-B:
36.44
NVO:
19.19
WSO-B:
3.45
NVO:
1.02
WSO-B:
2.58
NVO:
0.97
WSO-B:
7.20
NVO:
14.44
WSO-B:
$7.58B
NVO:
$303.14B
WSO-B:
$2.03B
NVO:
$255.65B
WSO-B:
$771.52M
NVO:
$154.08B
Returns By Period
In the year-to-date period, WSO-B achieves a -10.83% return, which is significantly higher than NVO's -22.75% return. Over the past 10 years, WSO-B has outperformed NVO with an annualized return of 17.71%, while NVO has yielded a comparatively lower 10.94% annualized return.
WSO-B
-10.83%
-6.47%
-8.08%
8.41%
28.80%
17.71%
NVO
-22.75%
1.04%
-37.93%
-49.62%
17.24%
10.94%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
WSO-B vs. NVO — Risk-Adjusted Performance Rank
WSO-B
NVO
WSO-B vs. NVO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Watsco Inc (WSO-B) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
WSO-B vs. NVO - Dividend Comparison
WSO-B's dividend yield for the trailing twelve months is around 2.35%, less than NVO's 2.46% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
WSO-B Watsco Inc | 2.35% | 1.97% | 2.32% | 3.39% | 2.49% | 2.97% | 3.53% | 4.14% | 2.72% | 2.42% | 2.36% | 1.87% |
NVO Novo Nordisk A/S | 2.46% | 1.68% | 1.00% | 1.20% | 1.34% | 1.86% | 2.14% | 2.47% | 2.12% | 3.93% | 1.31% | 1.96% |
Drawdowns
WSO-B vs. NVO - Drawdown Comparison
The maximum WSO-B drawdown since its inception was -61.63%, smaller than the maximum NVO drawdown of -71.29%. Use the drawdown chart below to compare losses from any high point for WSO-B and NVO. For additional features, visit the drawdowns tool.
Loading data...
Volatility
WSO-B vs. NVO - Volatility Comparison
Watsco Inc (WSO-B) and Novo Nordisk A/S (NVO) have volatilities of 14.14% and 14.82%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
WSO-B vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between Watsco Inc and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
WSO-B vs. NVO - Profitability Comparison
WSO-B - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Watsco Inc reported a gross profit of 429.62M and revenue of 1.53B. Therefore, the gross margin over that period was 28.1%.
NVO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Novo Nordisk A/S reported a gross profit of 65.20B and revenue of 78.09B. Therefore, the gross margin over that period was 83.5%.
WSO-B - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Watsco Inc reported an operating income of 112.19M and revenue of 1.53B, resulting in an operating margin of 7.3%.
NVO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Novo Nordisk A/S reported an operating income of 38.79B and revenue of 78.09B, resulting in an operating margin of 49.7%.
WSO-B - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Watsco Inc reported a net income of 80.06M and revenue of 1.53B, resulting in a net margin of 5.2%.
NVO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Novo Nordisk A/S reported a net income of 29.03B and revenue of 78.09B, resulting in a net margin of 37.2%.